Deutsche Bank Starts On Assignment (ASGN) at Buy; Cutting the Gap with Robert Half (RHI)
Tweet Send to a FriendGet Alerts ASGN Hot Sheet
Price: $26.88 -0.63%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 21
Trade ASGN Now!
Deutsche Bank initiates coverage on On Assignment (NASDAQ: ASGN) with a Buy. PT $21.00.
Deutsche analyst said, "On Assignment has the three exposures we want in a staffing company: IT, healthcare, and strong management. Then we are getting these optimal exposures at an attractive relative valuation. As On Assignment continues to put up strong growth and operating leverage, we think the discount to Robert Half (NYSE: RHI) will disappear. We initiate with 3QE EPS of $0.30 (Street $0.29), 4QE of $0.27 (Street $0.27), and 2013E EPS of $1.34 (Street $1.21)."
For an analyst ratings summary and ratings history on On Assignment click here. For more ratings news on On Assignment click here.
Shares of On Assignment closed at $15.79 yesterday, with a 52 week range of $6.27-$19.37.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Deutsche analyst said, "On Assignment has the three exposures we want in a staffing company: IT, healthcare, and strong management. Then we are getting these optimal exposures at an attractive relative valuation. As On Assignment continues to put up strong growth and operating leverage, we think the discount to Robert Half (NYSE: RHI) will disappear. We initiate with 3QE EPS of $0.30 (Street $0.29), 4QE of $0.27 (Street $0.27), and 2013E EPS of $1.34 (Street $1.21)."
For an analyst ratings summary and ratings history on On Assignment click here. For more ratings news on On Assignment click here.
Shares of On Assignment closed at $15.79 yesterday, with a 52 week range of $6.27-$19.37.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Wells Fargo Starts Quintiles (Q) at Outperform
- Morgan Stanley Starts Vantiv (VNTV) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Deutsche Bank
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
